An economic analysis of hand transplantation in the United States
- PMID: 19910847
- PMCID: PMC4387885
- DOI: 10.1097/PRS.0b013e3181c82eb6
An economic analysis of hand transplantation in the United States
Abstract
Background: Hand transplantation has received international attention in recent years; however, the economic impact of this innovative treatment is uncertain. The aim of this study was to assess the utility and estimate the costs of hand transplantation and the use of hand prostheses for forearm amputations.
Methods: One hundred medical students completed a time trade-off survey to assess the utilities of single and double hand transplantation and the use of hand prostheses. Quality-adjusted life years (QALYs) were calculated for each outcome to create decision trees. Cost data for medical care were estimated based on Medicare fee schedules using the Current Procedural Terminology code for forearm replantation. The cost of immunosuppressive therapy was estimated based on the wholesale price of drugs. The incremental cost-utility ratio was calculated from the differences in costs and utilities between transplantation and prosthesis. Sensitivity analyses were performed to assess the robustness of the results.
Results: For unilateral hand amputation, prosthetic use was favored over hand transplantation (30.00 QALYs versus 28.81 QALYs; p = 0.03). Double hand transplantation was favored over the use of prostheses (26.73 QALYs versus 25.20 QALYs; p = 0.01). The incremental cost-utility ratio of double transplantation when compared with prostheses was $381,961/QALY, exceeding the traditionally accepted cost-effectiveness threshold of $50,000/QALY.
Conclusions: Prosthetic adaption is the dominant strategy for unilateral hand amputation. For bilateral hand amputation, double hand transplantation exceeds the societally acceptable threshold for general adoption. Improvements in immunosuppressive strategies may change the incremental cost-utility ratio for hand transplantation.
Figures






Comment in
-
Discussion: An economic analysis of hand transplantation in the United States.Plast Reconstr Surg. 2010 Feb;125(2):599-600. doi: 10.1097/PRS.0b013e3181c831e5. Plast Reconstr Surg. 2010. PMID: 20124845 No abstract available.
Similar articles
-
Applying Health Utility Outcome Measures and Quality-Adjusted Life-Years to Compare Hand Allotransplantation and Myoelectric Prostheses for Upper Extremity Amputations.Plast Reconstr Surg. 2022 Mar 1;149(3):465e-474e. doi: 10.1097/PRS.0000000000008846. Plast Reconstr Surg. 2022. PMID: 35196684
-
Cost-effectiveness of Finger Replantation Compared With Revision Amputation.JAMA Netw Open. 2019 Dec 2;2(12):e1916509. doi: 10.1001/jamanetworkopen.2019.16509. JAMA Netw Open. 2019. PMID: 31790567 Free PMC article.
-
Discussion: An economic analysis of hand transplantation in the United States.Plast Reconstr Surg. 2010 Feb;125(2):599-600. doi: 10.1097/PRS.0b013e3181c831e5. Plast Reconstr Surg. 2010. PMID: 20124845 No abstract available.
-
Is Reconstruction of Unstable Midfoot Charcot Neuroarthropathy Cost Effective from a US Payer's Perspective?Clin Orthop Relat Res. 2020 Dec;478(12):2869-2888. doi: 10.1097/CORR.0000000000001416. Clin Orthop Relat Res. 2020. PMID: 32694315 Free PMC article.
-
[Hand transplantation - fiction or reality?].Ther Umsch. 2011 Dec;68(12):730-4. doi: 10.1024/0040-5930/a000237. Ther Umsch. 2011. PMID: 22139989 Review. German.
Cited by
-
History and ethics of hand transplants.JRSM Short Rep. 2012 Oct;3(10):74. doi: 10.1258/shorts.2012.011178. Epub 2012 Oct 26. JRSM Short Rep. 2012. PMID: 23162687 Free PMC article.
-
The evolution of functional hand replacement: From iron prostheses to hand transplantation.Plast Surg (Oakv). 2014 Spring;22(1):44-51. Plast Surg (Oakv). 2014. PMID: 25152647 Free PMC article. Review.
-
Education for patients with limb loss or absence: Aging, overuse concerns, and patient treatment knowledge gaps.Front Psychol. 2022 Sep 27;13:953113. doi: 10.3389/fpsyg.2022.953113. eCollection 2022. Front Psychol. 2022. PMID: 36237690 Free PMC article.
-
The cost-effectiveness of temozolomide in the adjuvant treatment of newly diagnosed glioblastoma in the United States.Neuro Oncol. 2013 Nov;15(11):1532-42. doi: 10.1093/neuonc/not096. Epub 2013 Aug 9. Neuro Oncol. 2013. PMID: 23935155 Free PMC article.
-
All hands on deck: Hand replantation versus transplantation.SAGE Open Med. 2020 May 27;8:2050312120926351. doi: 10.1177/2050312120926351. eCollection 2020. SAGE Open Med. 2020. PMID: 32537157 Free PMC article.
References
-
- Dubernard JM, Owen E, Herzberg G, et al. Human hand allograft: report on first 6 months. Lancet. 1999;353:1315–1320. - PubMed
-
- Jones JW, Gruber SA, Barker JH, et al. Successful hand transplantation. One-year follow-up. Louisville Hand Transplant Team. N Engl J Med. 2000;343:468–473. - PubMed
-
- Francois CG, Breidenbach WC, Maldonado C, et al. Hand transplantation: comparisons and observations of the first four clinical cases. Microsurgery. 2000;20:360–371. - PubMed
-
- Lanzetta M, Nolli R, Borgonovo A, et al. Hand transplantation: ethics, immunosuppression and indications. J Hand Surg [Br] 2001;26:511–516. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical